38546-07-5

Basic information

• Product Name: (8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-{[(3-oxo-3,4-dihydroisoquinolin-2(1H)-yl)amino]methylidene}-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate
• Synonyms: Rifamycin, 3-[[(3,4-dihydro-3-oxo-2(1H)-isoquinolinyl)imino]methyl]- (9CI)
• CAS NO: 38546-07-5
• Molecular Formula: C₄₇H₅₅N₃O₁₃
• Molecular Weight: 869.9519
• Mol File: 38546-07-5.mol
• Article Data: 1

Chemical Properties

• Density: 1.39g/cm³
• Refractive Index: 1.651
• PKA: 4?+-.0.70(Predicted)
• CAS DataBase Reference: (8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-{[(3-oxo-3,4-dihydroisoquinolin-2(1H)-yl)amino]methylidene}-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate(CAS DataBase Reference)
• NIST Chemistry Reference: (8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-{[(3-oxo-3,4-dihydroisoquinolin-2(1H)-yl)amino]methylidene}-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate(38546-07-5)
• EPA Substance Registry System: (8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-{[(3-oxo-3,4-dihydroisoquinolin-2(1H)-yl)amino]methylidene}-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate(38546-07-5)

Safety Data

• Hazardous Substances Data: 38546-07-5(Hazardous Substances Data)

Usage

Description

(8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-[(3-oxo-3,4-dihydroisoquinolin-2(1H)-yl)amino]methylidene-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate is a complex organic chemical compound characterized by its naphthofuran structure, multiple hydroxyl and methyl groups, an acetate functional group, and an amino group derived from 3-oxo-3,4-dihydroisoquinolin-2(1H)-yl. With a total of 40 carbon atoms and multiple double bonds, this compound exhibits a highly intricate molecular architecture.

Uses

1. Used in Pharmaceutical Industry:
(8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-[(3-oxo-3,4-dihydroisoquinolin-2(1H)-yl)amino]methylidene-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate is used as a potential therapeutic agent for various medical conditions due to its complex structure and functional groups that may interact with biological targets.
2. Used in Chemical Research:
In the field of chemical research, this compound can be utilized as a subject for studying the synthesis of complex organic molecules, understanding its reactivity, and exploring its potential applications in material science or as a precursor for other complex molecules.
3. Used in Material Science:
(8E,24E)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-8-[(3-oxo-3,4-dihydroisoquinolin-2(1H)-yl)amino]methylidene-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate's unique structure with multiple double bonds and functional groups may offer specific properties that could be harnessed in the development of new materials with tailored characteristics for various applications, such as in the electronics or aerospace industries.

Upstream product

• 39113-02-5 2-amino-1,4-dihydroisoquinolin-3(2H)-one 
• 13292-22-3 3-formylrifamycin SV 

Relevant articles and documents

Hydrazones of 3 formylrifamycin SV. Part III. N(mono and di)substituted hydrazone derivatives: synthesis, antibacterial activity and other biological properties

-